New EU Approvals
Executive Summary
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add a new product – Vafseo, Akebia Therapeutics’ treatment for symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis.